Opportunity Information: Apply for PA 07 226
Apply for PA 07 226
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Neuroscience Research on Drug Abuse (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Dec 5, 2008 and posted on Feb 21, 2007.
- Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: For profit organizations other than small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Private institutions of higher education Small businesses Native American tribal governments (Federally recognized) City or township governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments.
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith based or community based organizations can apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Neuroscience Research on Drug Abuse (R01) funding opportunity (PA 07 226) is a National Institutes of Health program announcement led by the National Institute on Drug Abuse (NIDA) that supports research aimed at explaining how drug abuse and addiction develop and persist at the level of brain and behavior. The central focus is on neuroscience and behavioral neuroscience studies that clarify the processes and mechanisms involved in drug use, progression to dependence and addiction, withdrawal, and treatment response. Proposed projects can use a wide range of approaches and experimental systems, including cellular or molecular model systems, animal studies, and human research, as long as the work is clearly relevant to understanding drug abuse and addiction.
This opportunity uses the NIH Research Project Grant (R01) mechanism, which is generally intended for more mature, hypothesis-driven projects with a well-developed research plan and sufficient preliminary rationale. NIDA notes that this FOA runs in parallel with companion announcements of the same scientific scope that use different grant mechanisms: an R03 (PA 07 228) for smaller, limited-scope projects and an R21 (PA 07 227) for exploratory or developmental work. In addition, similar or overlapping scientific topics may also be proposed under the Academic Research Enhancement Award (R15) mechanism, which is designed to support research at institutions that have not historically received substantial NIH research funding.
Funding levels and the number of awards are not preset. Instead, NIDA indicates that award size and project duration will vary depending on the nature and scope of the proposed work, and that the total amount funded and the number of grants made will ultimately depend on the number of applications received, their scientific quality, requested budgets, and project periods. There is no cost sharing or matching requirement listed for applicants.
Eligibility is broad and includes many types of domestic and international applicants. Eligible applicants include public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status, other than institutions of higher education as specified), for-profit organizations (including small businesses and other for-profits), independent school districts, and a range of government entities such as state, county, city or township, and special district governments. The announcement also allows applications from federally recognized Native American tribal governments, other tribal organizations, and public housing authorities/Indian housing authorities. Foreign institutions are explicitly eligible, and eligible federal agencies may apply as well. Faith-based and community-based organizations are also included as eligible applicants.
Administratively, the opportunity was posted on February 21, 2007, with multiple receipt dates rather than a single deadline, meaning applications could be submitted on recurring standard NIH due dates during the active period of the announcement. The original and current closing information both indicate multiple receipt dates with details provided in the full announcement. The program is now archived (archive date June 1, 2010), but the listing remains useful for understanding the program scope and how NIDA structured its neuroscience-focused addiction research solicitations. The full announcement was hosted through the NIH grants site, and NIH provided standard contact support through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.
Frequently Asked Questions (FAQs)
What is the Neuroscience Research on Drug Abuse (R01) opportunity (PA 07-226)?
Neuroscience Research on Drug Abuse (R01) (PA 07-226) is an NIH program announcement led by the National Institute on Drug Abuse (NIDA). It supports research that explains how drug abuse and addiction develop and persist at the level of brain and behavior, with a central focus on neuroscience and behavioral neuroscience.
Which NIH Institute leads this program announcement?
The opportunity is led by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH).
What scientific focus does this program emphasize?
The central emphasis is on neuroscience and behavioral neuroscience research aimed at clarifying processes and mechanisms involved in drug use and addiction, including how drug abuse begins, progresses, and persists.
What stages of addiction-related biology and behavior are within scope?
The announcement highlights research relevant to drug use, progression to dependence and addiction, withdrawal, and treatment response, as long as the work is clearly relevant to understanding drug abuse and addiction.
What types of studies and approaches are allowed?
A wide range of approaches and experimental systems are allowed, including cellular or molecular model systems, animal studies, and human research. The key requirement is that the project is clearly relevant to understanding drug abuse and addiction.
What funding mechanism is used?
This opportunity uses the NIH Research Project Grant (R01) mechanism.
What kinds of projects are typically suited to the R01 mechanism?
The R01 mechanism is generally intended for more mature, hypothesis-driven projects with a well-developed research plan and sufficient preliminary rationale.
Are there related announcements with the same scientific scope but different grant mechanisms?
Yes. NIDA noted that this FOA ran in parallel with companion announcements of the same scientific scope that used different mechanisms: an R03 (PA 07-228) for smaller, limited-scope projects and an R21 (PA 07-227) for exploratory or developmental work.
What is the difference between this R01 and the companion R03 and R21 announcements (based on the listing)?
Based on the provided information: the R01 is for more mature, hypothesis-driven projects; the R03 is for smaller, limited-scope projects; and the R21 is for exploratory or developmental research. The underlying scientific scope is described as the same across these companion announcements.
Can similar topics be proposed under any other NIH mechanism?
Yes. Similar or overlapping topics may also be proposed under the Academic Research Enhancement Award (R15) mechanism, which is designed to support research at institutions that have not historically received substantial NIH research funding.
Is the number of awards predetermined?
No. Funding levels and the number of awards are not preset. NIDA indicated that award size and project duration would vary based on the nature and scope of the proposed work.
How does NIDA decide how many projects to fund and at what levels?
According to the listing, the total amount funded and the number of grants made depend on factors such as the number of applications received, their scientific quality, the budgets requested, and the proposed project periods.
Is cost sharing or matching required?
No cost sharing or matching requirement is listed for applicants.
Who is eligible to apply?
Eligibility is broad and includes many types of domestic and international applicants. The listing includes public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status, as specified), for-profit organizations (including small businesses and other for-profits), independent school districts, and a range of government entities.
What types of U.S. government entities are eligible?
The listing includes eligibility for state, county, city or township, and special district governments.
Are tribal governments and tribal organizations eligible?
Yes. Applications are allowed from federally recognized Native American tribal governments and other tribal organizations.
Are public housing authorities eligible?
Yes. The announcement includes public housing authorities/Indian housing authorities as eligible applicants.
Are foreign (non-U.S.) institutions eligible?
Yes. Foreign institutions are explicitly eligible according to the provided information.
Can federal agencies apply?
Yes. Eligible federal agencies may apply as stated in the listing.
Are faith-based and community-based organizations eligible?
Yes. Faith-based and community-based organizations are included as eligible applicants.
When was this opportunity posted?
The opportunity was posted on February 21, 2007.
Does this program have a single deadline?
No. The opportunity used multiple receipt dates rather than a single deadline, meaning applications could be submitted on recurring standard NIH due dates during the active period of the announcement.
Where are the receipt date details provided?
The listing indicates that details on the multiple receipt dates are provided in the full announcement.
Is this funding opportunity still active?
No. The program is archived, with an archive date of June 1, 2010.
If it is archived, why might the listing still matter?
The listing remains useful for understanding the program scope and how NIDA structured its neuroscience-focused addiction research solicitations.
Where was the full announcement hosted?
The full announcement was hosted through the NIH grants site.
Who provided contact support for access or linking issues?
NIH provided standard contact support through the NIH Office of Extramural Research (OER) webmaster for access or linking issues.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Neuroscience Research on Drug Abuse (R21)
Previous opportunity: Developmental Psychopharmacology (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 07 226
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 07 226) also looked into and applied for these:
| Funding Opportunity |
|---|
| Neuroscience Research on Drug Abuse (R21) Apply for PA 07 227 Funding Number: PA 07 227 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Neuroscience Research on Drug Abuse(R03) Apply for PA 07 228 Funding Number: PA 07 228 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Collaborative Clinical Trials in Drug Abuse (R01) Apply for PAR 07 232 Funding Number: PAR 07 232 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01) Apply for PA 07 329 Funding Number: PA 07 329 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21) Apply for PA 07 331 Funding Number: PA 07 331 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03) Apply for PA 07 330 Funding Number: PA 07 330 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Amphetamine and Amphetamine Like Related Disorders (R01) Apply for PA 07 333 Funding Number: PA 07 333 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Amphetamine and Amphetamine Like Related Disorders (R21) Apply for PA 07 334 Funding Number: PA 07 334 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of Animal Models and Related Biological Materials For Research (R21) Apply for PA 07 336 Funding Number: PA 07 336 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV Treatment Adherence Research (R01) Apply for PA 07 338 Funding Number: PA 07 338 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV Treatment Adherence Research (R03) Apply for PA 07 339 Funding Number: PA 07 339 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV Treatment Adherence Research (R21) Apply for PA 07 340 Funding Number: PA 07 340 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Developing And Improving Institutional Animal Resources (G20) Apply for PAR 07 342 Funding Number: PAR 07 342 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| AIDS Science Track Award for Research Transition (R03) Apply for PA 07 349 Funding Number: PA 07 349 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Bioengineering and Obesity (R01) Apply for PA 07 354 Funding Number: PA 07 354 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Improving Heart Failure Disease Management (R01) Apply for PA 07 355 Funding Number: PA 07 355 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical Cancer Therapy and Prevention Research (R01) Apply for PA 07 356 Funding Number: PA 07 356 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components (R21) Apply for PA 07 362 Funding Number: PA 07 362 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Cannabis Related Disorders (R01) Apply for PA 07 365 Funding Number: PA 07 365 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Cannabis Related Disorders (R21) Apply for PA 07 366 Funding Number: PA 07 366 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 226", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.